The folks at Marijuana Moment now have two lengthy posts discussing the recent filings in a lawsuit challenging the federal gun prohibitions applicable to medical marijuana users. Here are links to the stories and excerpts: “Biden DOJ Says Medical Marijuana
A Green Light for Canna-Research? Medical Marijuana and CBD Research Bill on the Cusp
The House has passed a revised version of the Medical Marijuana and Cannabidiol Research Expansion Act, HR 8454, sending it back to the Senate for action. With previous bipartisan approval, the legislation is expected to soon head to the President’s
RICO Suit Filed Regarding Alleged Inflation of THC Amounts in Medical Cannabis Products
A class-action lawsuit was filed on July 12 in the U.S. District Court for the Eastern District of Arkansas alleging that cannabis testing companies inflated the amount of THC found in cannabis flower. Plaintiffs are a putative class of medical
States to Feds: End Cannabis Prohibition Now
After a vote last week, the National Conference of State Legislators (NCSL) adopted a revised cannabis policy measure (the “Directive“) which supports federally descheduling cannabis, as well as cannabis banking reform. At this point, it’s abundantly clear that
"Synthetic cannabinoid poisonings and access to the legal cannabis market: findings from US national poison centre data 2016–2019"
The title of this this post is the title of this notable new research just published in the journal Clinical Toxicology. Here is its abstract: Aim To investigate trends in synthetic cannabinoid exposures reported to United States (US) poison control
Interstate Cannabis Agreements in California
I get asked a lot of questions about what California cannabis licensees can and cannot do under the Medicinal and Adult-Use Cannabis Regulation and Safety Act (“MAUCRSA”). California is actually business friendly once operations get going with a license– despite
Agency Head Announces Departure: What’s Next for Michigan’s Cannabis Industry
Yesterday, it became public that Michigan Cannabis Regulatory Agency Executive Director Andrew Brisbo will soon be leaving the agency.
Having spent nearly two decades working in licensing and regulation with the state of Michigan, Director Brisbo served with distinction as
Deceptive Matter and Canna Brands
Deceptive matter is yet another pitfall faced by canna brands as they take steps to protect their intellectual property. According to the U.S. Trademark Act (commonly known as the Lanham Act), such matter may not be registered as a
New York CAURD Locations: The Update
We recently got on our soap box about the importance of hiring a New York cannabis attorney. The catalyst for that post was the question of whether applicants for New York’s Conditional Adult-Use Retail Dispensary (CAURD) license can select their
Effective review of the state of new state marijuana reforms in 2022
With lots of bills being introduced and debated at the federal level, it is dangerously easy to overlook the fact that marijuana reform in the US has been almost exclusively a state story for a quarter century and is likely